What is the current price and volume for GV.PA stock?

GV.PA stock is trading at **€0.0018** intraday with **38,489,238** shares traded today, versus an average volume of **14,217,513**. The day high is **€0.0020** and day low is **€0.0015**.

What is Meyka AI’s rating for GV.PA stock?

Meyka AI rates GV.PA with a score of **62.53** out of 100, Grade **B** with a **HOLD** suggestion. The grade factors benchmark and sector comparisons, financials, key metrics, forecasts, and analyst signals.

What price targets and forecast exist for GV.PA stock?

Meyka AI's model projects a 12-month base target of **€0.00500** (+**177.78%**). A conservative bear case is **€0.00100** (-**44.44%**) and a bull case **€0.01500** (+**733.33%**). Forecasts are projections, not guarantees.

What are the main risks for GV.PA stock investors?

Primary risks for GV.PA stock include very low market cap and liquidity, negative EPS **-0.11**, potential equity dilution, long cash conversion cycles, and dependence on commercialization catalysts and regulatory validation.

EU Stocks

GV.PA Genomic Vision SA on EURONEXT 23 Feb 2026: Intraday most active at €0.0018

ByHuzaifa Zahoor February 23, 2026February 23, 2026

GV.PA stock is the day’s most active name on EURONEXT intraday, trading at €0.0018, up 5.88%, on 38,489,238 shares versus a 14,217,513 average. We see a large relative volume spike (2.71x) driving short-term price action. Genomic Vision SA (GV.PA) remains a micro‑cap (€693,191 market cap) listed in Europe in the Healthcare diagnostics sector. As an AI-powered market analysis platform, Meyka AI tracks this move for liquidity, valuation and event risk that matter to short-term traders and long-term speculators.